Part, Chapter, Paragraph
1 I, 2. 10. 4| and locations in a faster, accurate, more efficient way and
2 II, 5. 2. 2| the last year for which accurate data is available for the
3 II, 5. 3. 7| appropriate specialists for accurate diagnosis and subsequent
4 II, 5. 4. 1| diabetes are scarce and not accurate.~The most complete resource
5 II, 5. 4. 2| large scale, including an accurate measurement of the prevalence
6 II, 5. 4. 2| their role in providing accurate clinical information.~On
7 II, 5. 4. 2| To make the profile more accurate, such information can be
8 II, 5. 4. 2| Registers may become the most accurate source, but they need to
9 II, 5. 4. 3| 10 countries delivering accurate data. The median value is
10 II, 5. 5. 2| impossible to obtain an accurate estimation of the number
11 II, 5. 5. 3| intervention (WHO, 2005):~· provide accurate and reliable information;~·
12 II, 5. 5. 3| general there are little accurate comparative data on prescribing
13 II, 5. 5. 3| information systems.~Not even accurate hospital morbidity data
14 II, 5. 5. 3| criteria would allow a more accurate comparison of national and
15 II, 5. 7. 7| N, Roth D (1999): A more accurate method to estimate glomerular
16 II, 5. 9. FB| follow-up. An early and accurate diagnosis is crucial as
17 II, 5. 9. FB| definition of reliable and accurate diagnostic tools is important
18 II, 5. 10. 4| 4. Data discussion~ ~An accurate estimation of the real prevalence
19 II, 7. 4. 7| is neither sufficiently accurate nor detailed. In addition,
20 II, 9. 3. 2| risk for maternal death. Accurate MMRs require the inclusion
21 III, 10. 2. 1| in Europe have developed accurate treatment modalities and
22 III, 10. 2. 1| wish, provided that it is accurate and does not mislead the
23 III, 10. 2. 1| label in the EU is clear, accurate and substantiated. In doing
24 III, 10. 6. 3| police is not sufficiently accurate or detailed. In addition,
25 IV, 11. 1. 6| require an unbiased and accurate risk adjustment process,
